Tag: Mad in America Continuing Education

Continuing our 200th podcast, staff members join us to discuss reinvigorating MIA continuing education, science writing and blogs, personal stories, community commenting and family resources.

The failures of our current drug-based paradigm of psychiatric care tell of a pressing need for systemic changes in psychiatry. But as we discovered when marketing our new continuing education course on this topic, it's always difficult to promote radical change.

Starting on September 17, Mad in America will be offering a series of monthly webinars how to make changes in real-world programs that reflect the progressive reform agendas that embody a "green" revolution in mental health care. Enroll now!

As 2019 begins, we at Mad in America are looking forward to continuing to broaden our efforts to provide informational and educational resources that will help our society "rethink psychiatry." The start of the New Year also provides us with an opportunity to look back and tally up our efforts in 2018.

With this second course we are focusing on the challenges that drug withdrawal presents to prescribers as more and more people seek to come off medications. As many have noted, prescribers may have extensive experience getting patients on psychiatric medications and then managing their drug use, but little or no experience helping patients taper off the drugs.

A full picture of the seven webinars that comprise our upcoming psychiatric withdrawal course, with presenters including Sandra Steingard, Peter Breggin, Kelly Brogan, Carina Hakansson, Will Hall and a panel of survivors. The course begins on October 24th and slots are filling fast!

The pharmaceutical industry has long funded CEU and CME curriculums, with the predictable result that the knowledge base, where it exists at all, is tainted by commercial interest. We have a critical vacuum to fill, and intend to keep doing so until the field is fully saturated with unbiased professional education.

Within days of announcing the webinar and providing the link to register, we were deluged with enrollments. It turns out that a great many professionals, advocates and clinical managers are interested in learning about Open Dialogue and its application to an American community.

SAMHSA should be commended for undertaking an important educational task with laudable goals. Unfortunately, I have to conclude that SAMHSA’s Recovery to Practice module on medications for psychiatrists is a very minimal and even misleading attempt at educating psychiatrists.